|We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.|
Cambridge Heart is a thinly traded stock, Company makes enhanced
EKG-like analyzers that detect tiny T-alternans currents in cardiac
patients. Early studies indicate a high correlations between detecting
these T-alternans waves and being at 50% risk of sudden death.
If no t-alternans waves are seen, the risk for sudden death is 8%.
Medtronic has signed a letter of intent ( for what's that worth ) to
partner with CAMH.
Does anyone know more?
|© 2021 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News|